Time-Lapse Imaging of Neuronal Arborization using Sparse Adeno-Associated Virus Labeling of Genetically Targeted Retinal Cell Populations
March 19th, 2021
Here, we present a method for investigating neurite morphogenesis in postnatal mouse retinal explants by time-lapse confocal microscopy. We describe an approach for sparse labeling and acquisition of retinal cell types and their fine processes using recombinant adeno-associated virus vectors that express membrane-targeted fluorescent proteins in a Cre-dependent manner.
Overview
This article presents a detailed protocol for sparse labeling and live imaging of developing dendritic arbors in specific retinal cell populations in the mouse. By combining Cre-dependent adeno-associated virus (AAV) delivery of membrane-targeted fluorescent proteins with confocal microscopy, the method enables high-resolution, time-lapse visualization of dendrite dynamics in retinal explants. The protocol includes steps for tissue preparation, imaging, and advanced postprocessing to enhance structural and temporal resolution, facilitating the study of neuronal morphogenesis in situ.
Key Study Components
Area of Science
- Neuroscience
- Developmental Biology
- Imaging Techniques
Background
- Understanding dendritic arborization is crucial for elucidating neuronal connectivity and morphogenesis.
- The mouse retina is a well-characterized model system with defined cell types and available genetic tools.
- Many retinal neurons restrict their dendrites to specific layers, aiding in imaging and analysis.
- Existing methods for live imaging of dendrite dynamics with high temporal and structural resolution are limited.
Purpose of Study
- To develop a minimally invasive protocol for sparse, cell type-specific labeling of retinal neurons during development.
- To enable high-resolution, live imaging of dendritic dynamics in intact retinal explants.
- To provide a postprocessing pipeline for deconvolution and 3D drift correction of imaging data.
Methods Used
- Selection of Cre mouse lines to target specific retinal cell populations.
- Intraocular injection of Cre-dependent AAVs encoding membrane-targeted fluorescent proteins in neonatal mice.
- Preparation and mounting of retinal flat-mounts in oxygenated artificial cerebrospinal fluid (aCSF) for live imaging.
- Confocal microscopy to acquire 3D time-lapse images of labeled dendrites.
- Image postprocessing including deconvolution and 3D drift correction using ImageJ plugins and macros.
Main Results
- Efficient, sparse labeling of targeted retinal neurons is achieved within 4–5 days post-injection.
- High-resolution, time-lapse 3D videos of dendritic development and dynamics are obtained.
- Deconvolution enhances visualization of fine dendritic structures such as filopodia.
- Sample drift during imaging is minimized by temperature control and proper sample weighting, with manual adjustments as needed.
Conclusions
- This protocol enables detailed, live imaging of dendritic morphogenesis in the developing retina.
- The approach is adaptable for studying neuronal development in other regions of the central nervous system.
- High-quality imaging data generated by this method can advance computational analysis and understanding of neuronal wiring.
Frequently Asked Questions
Executive Industry Relevance
High-resolution time-lapse imaging of neuronal arborization in genetically defined retinal populations enables precise interrogation of neuronal morphogenesis and connectivity. This capability supports early discovery efforts by providing quantitative, dynamic insights into dendritic development and remodeling, which are critical for target validation and mechanistic de-risking in neurobiology-focused pipelines. The method's adaptability to other CNS regions enhances its portfolio value for translational neuroscience R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables visualization of single-cell dendritic dynamics for mechanistic hypothesis testing.
- Supports functional target validation by resolving fine neuronal structures in situ.
- Facilitates biological de-risking through direct observation of developmental processes.
- Provides quantitative data for predictive confidence in neuronal pathway studies.
Screening & Assay Development
- Prepares validated, genetically targeted retinal systems for downstream imaging workflows.
- Delivers reproducible, high-resolution imaging outputs suitable for quantitative analysis.
- Supports assay standardization by enabling consistent labeling and imaging conditions.
- Enables reliable evaluation of neuronal morphology-modulating compounds.
Translational & Preclinical Research
- Aligns with disease-relevant models by leveraging the well-characterized mouse retina.
- Provides continuity from discovery to preclinical validation for CNS development studies.
- Enables risk-adjusted advancement decisions based on dynamic morphogenesis data.
- Supports identification of translational biomarkers linked to neuronal structure and function.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling dynamic, quantitative analysis of neuronal development in genetically defined systems.
- Discovery Biology: Supports hypothesis testing and pathway clarification through live imaging of dendritic arborization.
- Screening: Provides reproducible, quantitative imaging outputs for comparative analysis of experimental conditions.
- Analytics: Generates high-resolution, deconvolved 3D videos and quantitative morphometric data for robust statistical analysis.
- Translational Research: Bridges discovery and preclinical research by enabling mechanistic studies in disease-relevant retinal models.
- Enterprise Reuse: Offers a reusable imaging and analysis platform adaptable to various neuronal populations and CNS regions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neuronal development studies.
- Operational Value: Standardizes imaging workflows and enhances reproducibility across experiments.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by providing robust, quantitative data early in the pipeline.
- Portfolio Impact: Enables risk-adjusted prioritization of neurodevelopmental targets and pathways.
Implementation Considerations
- Requires expertise in genetic targeting, AAV handling, and advanced confocal imaging.
- Demands access to confocal or multiphoton microscopy and computational postprocessing infrastructure.
- Necessitates cross-team standardization of labeling, imaging, and analysis protocols.
- Adaptable to other CNS models with appropriate Cre lines and injection strategies.
- Limited by current throughput of manual tracing and need for improved automated analysis tools.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:58
Adeno-Associated Virus (AAV) Preparation and Intravitreal Injection of Neonatal Mice
3:13
Retinal Dissections for Live-Imaging Experiment
5:04
Retinal Flat-Mount Preparation
6:35
Time-Lapse Confocal Imaging of Live Whole-Mount Retina Preparations
8:33
Image Deconvolution and Post-Processing in ImageJ
11:16
Results: Representative Results After Neonatal Intraocular Injection, Time-Lapse Imaging, and Deconvolution
12:13
Conclusion
